These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21401963)

  • 1. Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera.
    Batra G; Nemani SK; Tyagi P; Swaminathan S; Khanna N
    BMC Infect Dis; 2011 Mar; 11():64. PubMed ID: 21401963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes.
    Hapugoda MD; Batra G; Abeyewickreme W; Swaminathan S; Khanna N
    Clin Vaccine Immunol; 2007 Nov; 14(11):1505-14. PubMed ID: 17898184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.
    Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG
    Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and preliminary application of dengue virus envelope domain III IgG antibody capture enzyme-linked immuno-absorbent assay].
    Hu DM; Cai JP; Wang DH; DI B; Qiu LW; Wang YD; Chen Y; Ding XX; Che XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):363-6. PubMed ID: 23928645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA.
    Emmerich P; Mika A; Schmitz H
    PLoS Negl Trop Dis; 2013; 7(12):e2580. PubMed ID: 24386498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
    Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
    Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
    Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.
    Wahala WM; Kraus AA; Haymore LB; Accavitti-Loper MA; de Silva AM
    Virology; 2009 Sep; 392(1):103-13. PubMed ID: 19631955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Envelope-Proteins with Mutations in the Conserved Fusion Loop Allow Specific Serological Diagnosis of Dengue-Infections.
    Rockstroh A; Barzon L; Pacenti M; Palù G; Niedrig M; Ulbert S
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004218. PubMed ID: 26565964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification.
    Nagar PK; Savargaonkar D; Anvikar AR
    J Immunol Res; 2020; 2020():1820325. PubMed ID: 32832567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serodiagnosis of dengue virus infection using commercially available antibody and NS1 antigen ELISAs.
    Granger D; Leo YS; Lee LK; Theel ES
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):120-124. PubMed ID: 28389145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis.
    Niu G; Pang Z; Guan C; Qi J; Li D
    Virus Res; 2015 Apr; 201():73-8. PubMed ID: 25697685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies.
    Lee H; Ryu JH; Park HS; Park KH; Bae H; Yun S; Choi AR; Cho SY; Park C; Lee DG; Lim J; Lee J; Lee S; Shin S; Park H; Oh EJ
    Ann Lab Med; 2019 Nov; 39(6):566-571. PubMed ID: 31240885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India.
    Kulkarni R; Modak M; Gosavi M; Wani D; Mishra AC; Arankalle VA
    Indian J Med Res; 2020 Jan; 151(1):71-78. PubMed ID: 32134017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine.
    Zhao H; Jiang T; Zhou XZ; Deng YQ; Li XF; Chen SP; Zhu SY; Zhou X; Qin ED; Qin CF
    PLoS One; 2014; 9(1):e86573. PubMed ID: 24466156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a rapid immunochromatographic device for the detection of IgM & IgG antibodies to dengue viruses (DENV) in a tertiary care hospital in south India.
    Moorthy M; Chandy S; Selvaraj K; Abraham AM
    Indian J Med Microbiol; 2009; 27(3):254-6. PubMed ID: 19584509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.